EA202192530A1 - Соединения, композиции и способы - Google Patents
Соединения, композиции и способыInfo
- Publication number
- EA202192530A1 EA202192530A1 EA202192530A EA202192530A EA202192530A1 EA 202192530 A1 EA202192530 A1 EA 202192530A1 EA 202192530 A EA202192530 A EA 202192530A EA 202192530 A EA202192530 A EA 202192530A EA 202192530 A1 EA202192530 A1 EA 202192530A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- compositions
- compounds
- tautomer
- stereoisomer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 229940124786 LRRK2 inhibitor Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832775P | 2019-04-11 | 2019-04-11 | |
| PCT/US2020/027742 WO2020210684A1 (en) | 2019-04-11 | 2020-04-10 | Compounds, compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192530A1 true EA202192530A1 (ru) | 2022-03-15 |
Family
ID=72752101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192530A EA202192530A1 (ru) | 2019-04-11 | 2020-04-10 | Соединения, композиции и способы |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US12358896B2 (https=) |
| EP (1) | EP3953348B1 (https=) |
| JP (1) | JP7623294B2 (https=) |
| KR (1) | KR20210151887A (https=) |
| CN (1) | CN113939294A (https=) |
| AR (1) | AR118641A1 (https=) |
| AU (1) | AU2020272045B2 (https=) |
| BR (1) | BR112021020027A2 (https=) |
| CA (1) | CA3136447A1 (https=) |
| DK (1) | DK3953348T3 (https=) |
| EA (1) | EA202192530A1 (https=) |
| ES (1) | ES3018383T3 (https=) |
| IL (1) | IL287120B2 (https=) |
| MA (1) | MA55624A (https=) |
| MX (1) | MX2021012392A (https=) |
| SG (1) | SG11202111058XA (https=) |
| TW (1) | TWI851710B (https=) |
| WO (1) | WO2020210684A1 (https=) |
| ZA (1) | ZA202107499B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112088003B (zh) | 2017-12-20 | 2023-10-13 | 戴纳立制药公司 | 制备嘧啶基-4-氨基吡唑化合物的工艺 |
| EP4238975A4 (en) * | 2020-10-29 | 2024-06-12 | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | SUBSTITUTED DIARYLAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, MANUFACTURING PROCESS THEREOF AND USE THEREOF |
| CN116120291B (zh) * | 2023-04-11 | 2023-06-30 | 英矽智能科技(上海)有限公司 | 吲唑类化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2638031T3 (https=) | 2010-11-10 | 2018-03-10 | ||
| SMT202100699T1 (it) | 2016-06-16 | 2022-01-10 | Denali Therapeutics Inc | Pirimidin-2-ilammino-1h-pirazoli come inibitori di lrrk2 per l'uso nel trattamento di disturbi neurodegenerativi |
| WO2018217946A1 (en) | 2017-05-24 | 2018-11-29 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CN112088003B (zh) | 2017-12-20 | 2023-10-13 | 戴纳立制药公司 | 制备嘧啶基-4-氨基吡唑化合物的工艺 |
-
2020
- 2020-04-08 AR ARP200101008A patent/AR118641A1/es unknown
- 2020-04-10 US US17/602,480 patent/US12358896B2/en active Active
- 2020-04-10 SG SG11202111058XA patent/SG11202111058XA/en unknown
- 2020-04-10 CN CN202080041217.0A patent/CN113939294A/zh active Pending
- 2020-04-10 IL IL287120A patent/IL287120B2/en unknown
- 2020-04-10 JP JP2021559818A patent/JP7623294B2/ja active Active
- 2020-04-10 TW TW109112173A patent/TWI851710B/zh active
- 2020-04-10 EP EP20787582.4A patent/EP3953348B1/en active Active
- 2020-04-10 ES ES20787582T patent/ES3018383T3/es active Active
- 2020-04-10 WO PCT/US2020/027742 patent/WO2020210684A1/en not_active Ceased
- 2020-04-10 CA CA3136447A patent/CA3136447A1/en active Pending
- 2020-04-10 DK DK20787582.4T patent/DK3953348T3/da active
- 2020-04-10 MX MX2021012392A patent/MX2021012392A/es unknown
- 2020-04-10 MA MA055624A patent/MA55624A/fr unknown
- 2020-04-10 BR BR112021020027A patent/BR112021020027A2/pt unknown
- 2020-04-10 KR KR1020217036412A patent/KR20210151887A/ko active Pending
- 2020-04-10 AU AU2020272045A patent/AU2020272045B2/en active Active
- 2020-04-10 EA EA202192530A patent/EA202192530A1/ru unknown
-
2021
- 2021-10-05 ZA ZA2021/07499A patent/ZA202107499B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3953348A1 (en) | 2022-02-16 |
| CN113939294A (zh) | 2022-01-14 |
| TWI851710B (zh) | 2024-08-11 |
| EP3953348B1 (en) | 2024-12-18 |
| ZA202107499B (en) | 2022-06-29 |
| JP2022526015A (ja) | 2022-05-20 |
| ES3018383T3 (es) | 2025-05-16 |
| JP7623294B2 (ja) | 2025-01-28 |
| CA3136447A1 (en) | 2020-10-15 |
| SG11202111058XA (en) | 2021-11-29 |
| IL287120B1 (en) | 2025-02-01 |
| EP3953348A4 (en) | 2023-01-18 |
| TW202104213A (zh) | 2021-02-01 |
| AR118641A1 (es) | 2021-10-20 |
| WO2020210684A1 (en) | 2020-10-15 |
| AU2020272045B2 (en) | 2026-01-15 |
| KR20210151887A (ko) | 2021-12-14 |
| IL287120B2 (en) | 2025-06-01 |
| AU2020272045A1 (en) | 2021-10-28 |
| MX2021012392A (es) | 2021-11-12 |
| MA55624A (fr) | 2022-02-16 |
| US12358896B2 (en) | 2025-07-15 |
| US20220220094A1 (en) | 2022-07-14 |
| IL287120A (en) | 2021-12-01 |
| DK3953348T3 (da) | 2025-03-17 |
| BR112021020027A2 (pt) | 2021-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA518400660B1 (ar) | مركبات بيرميدين-2-يل أمينو -1h- بيرازول في صورة مثبطات لاستخدامها في علاج الاضطرابات التنكسية العصبيةlrrk2 | |
| SA520411222B1 (ar) | مركبات بوصفها معدلات لعامل باديء حقيقي النواة 2ب وتركيبات وطرق | |
| ZA202105930B (en) | Compounds, compositions and methods | |
| CR20220234A (es) | Degradadores de moléculas pequeñas de helios y procedimientos de uso | |
| PH12018501956A1 (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
| PH12018500147A1 (en) | Benzodiazepine derivatives as rsv inhibitors | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| EA201992299A1 (ru) | Соединения на основе ингибиторов ask1 и их применение | |
| MX389592B (es) | Moduladores alostericos positivos del receptor m1 muscarinico | |
| EA201790525A1 (ru) | Применение агента, активирующего рецептор гамк, для получения седативного и анестезирующего лекарственного средства | |
| EA202092829A1 (ru) | Композиции тофацитиниба с контролируемым высвобождением | |
| EA202190681A1 (ru) | Амиды диметиламиноазетидина в качестве jak ингибиторов | |
| EA201992116A1 (ru) | Фармацевтические составы флороглюцинола и триметилфлороглюцинола | |
| UY38614A (es) | Derivados de benzodiazepinas como inhibidores del rsv | |
| MX2020013694A (es) | Compuestos heterocíclicos como inhibidores de trk. | |
| PH12021551873A1 (en) | Hydroxypyridoxazepines as nrf2 activators | |
| EA202192530A1 (ru) | Соединения, композиции и способы | |
| PH12021551057A1 (en) | Macrocyclic tyrosine kinase inhibitor and uses thereof | |
| MX2023013683A (es) | Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a). | |
| EA202192845A1 (ru) | Новые композиции, содержащие мелфлуфен | |
| JOP20190050A1 (ar) | مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي | |
| MX2021012248A (es) | Polimorfos de voruciclib y metodos de elaboracion y uso de los mismos. | |
| EA201991355A1 (ru) | Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта | |
| EA202192760A1 (ru) | Трициклические соединения | |
| WO2020009675A3 (en) | Solid oral pharmaceutical compositions of linagliptin |